Novo Nordisk A/S
Novo Nordisk's Climate Target Data Preview
As of 2024, Novo Nordisk has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 absolute reduction target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Novo Nordisk ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target* | Scope 3 - Purchased Goods and Services (Cat. 1), Scope 3 - Capital Goods (Cat. 2), Scope 3 - Upstream Transportation and Distribution (Cat. 4), Scope 3 - Downstream Transportation and Distribution (Cat. 9), Scope 3 - Business Travel (Cat. 6), Scope 3 - Upstream Leased Assets (Cat. 8) | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2033 |
This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Novo Nordisk's Greenhouse Gas Emissions Pathways
As of 2024, Novo Nordisk has set greenhouse gas (GHG) emissions reduction targets that cover its value chain emissions (Scope 3), without dedicated targets for its operational emissions. This indicates a focus on upstream and downstream climate impacts rather than internal operations.
Does Novo Nordisk have a target to reduce the emissions from its value chain?
As of 2024, Novo Nordisk has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 6 out of the 15 Scope 3 categories defined by the GHG Protocol.
Novo Nordisk's most ambitious value chain target is to reduce these emissions by 33% by 2033, compared to a baseline of 1,493,000 Metric Tonnes of CO2 equivalent (mtCO2e) in 2024.